Viewing Study NCT00035334

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-01-08 @ 6:53 AM
Study NCT ID: NCT00035334
Status: COMPLETED
Last Update Posted: 2006-02-14
First Post: 2002-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
Sponsor: Bellus Health Inc. - a GSK company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Secondary (AA) Amyloidosis View
None Rheumatoid Arthritis View
None Nephrotic Syndrome View
None Familial Mediterranean Syndrome View
None Kidney Diseases View
None Gastrointestinal Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Familial Mediterranean Fever View
None Amyloidosis View
None Secondary (AA) Amyloidosis View
None Nephrotic Syndrome View